DC
ATRC icon

Decheng Capital’s AtriCure ATRC Stock Holding History

Decheng Capital’s Portfolio ATRC Stock Details ATRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-26,797
Closed -$819K – 28
2024
Q4 		$819K Hold
26,797
– – 0.18% 25
2024
Q3 		$751K Hold
26,797
– – 0.18% 23
2024
Q2 		$610K Hold
26,797
– – 0.19% 21
2024
Q1 		$815K Sell
26,797
-19,462
-42% -$652K 0.11% 22
2023
Q4 		$1.65M Buy
+46,259
New +$1.72M 0.46% 19

Other funds holding ATRC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Decheng Capital's ATRC Position: Q1 2025 in Review

Decheng Capital sold out of AtriCure (ATRC) in Q1 2025, closing a stake of 26,797 shares — an estimated $819K sold.

Decheng Capital first reported a position in ATRC in Q4 2023 and held it in 5 quarters. The position peaked at $1.65M in Q4 2023. 221 funds tracked by Wall St. Rank hold ATRC as of Q1 2025.

  • Decheng Capital reported no remaining AtriCure position as of Q1 2025 after selling out during the quarter.
  • Decheng Capital sold 26,797 AtriCure shares in Q1 2025, an estimated $819K.
  • Decheng Capital first reported a position in AtriCure in Q4 2023 and held it in 5 quarters.
  • Decheng Capital's AtriCure position peaked at $1.65M in Q4 2023.
  • 221 funds tracked by Wall St. Rank held AtriCure as of Q1 2025.

Based on Decheng Capital's 13F filing for Q1 2025, filed 8 May 2025.